Please ensure Javascript is enabled for purposes of website accessibility Circular 89 of 2026- Voluntary Recall of Methyldopa 250 mg FC tablets, B.No. 120115, 122608, 104878, 105371, 109619, 112018, 113602, 113603 & 116224 - from M/S Remedica- Cyprus Circular 89 of 2026- Voluntary Recall of Methyldopa 250 mg FC tablets, B.No. 120115, 122608, 104878, 105371, 109619, 112018, 113602, 113603 & 116224 - from M/S Remedica- Cyprus

Circular 89 of 2026- Voluntary Recall of Methyldopa 250 mg FC tablets, B.No. 120115, 122608, 104878, 105371, 109619, 112018, 113602, 113603 & 116224 - from M/S Remedica- Cyprus

Content Details
Pharmacovigilance Department Recall and withdrawals
Circular 89 of 2026- Voluntary Recall of Methyldopa 250 mg FC tablets, B.No. 120115, 122608, 104878, 105371, 109619, 112018, 113602, 113603 & 116224 - from M/S Remedica- Cyprus
27/09/2026

Circular 89 of 2026- Voluntary Recall of Methyldopa 250 mg FC tablets, B.No. 120115, 122608, 104878, 105371, 109619, 112018, 113602, 113603 & 116224 - from M/S Remedica- Cyprus

0
Circular 89 of 2026- Voluntary Recall of Methyldopa 250 mg FC tablets, B.No. 120115, 122608, 104878, 105371, 109619, 112018, 113602, 113603 & 116224 - from M/S Remedica- Cyprus
Was this page helpful?
0 visitors liked this page of total 0 visitors
Be the first to evaluate this page

Add Reason (choose at least one)

الرجاء اختيار سببان كحد أعلى

هذا الحقل مطلوب

الرجاء كتابة نص صحيح

الملاحظات يجب ان تكون اقل من ٢٥٠ حرف

//
Last updated: 2 days ago (2026/09/28)
Follow Us On